Abstract
Malignant hyperthermia is a hypermetabolic response to inhalation agents (such as halothane, sevoflurane, and desflurane), succinylcholine, vigorous exercise, and heat. Reactions develop more frequently in males than females (2 : 1). The classical signs of malignant hyperthermia are hyperthermia, tachycardia, tachypnea, increased carbon dioxide production, increased oxygen consumption, acidosis, muscle rigidity and rhabdomyolysis. In this case report, we present a case of delayed onset malignant hyperthermia-like reaction after the second exposure to sevoflurane.
Cite
CITATION STYLE
Turhan, K. S. C., Baytaş, V., Batislam, Y., & Özatamer, O. (2013). Delayed Onset Malignant Hyperthermia after Sevoflurane. Case Reports in Anesthesiology, 2013, 1–3. https://doi.org/10.1155/2013/712710
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.